Researchers have developed a non-chemotherapy treatment regimen that is achieving full remissions for some people with aggressive B-cell lymphoma that has come back or is no longer responding to standard treatments. The five-drug combination targets multiple molecular pathways that diffuse large B-cell lymphoma (DLBCL) tumors use to survive.
source https://www.sciencedaily.com/releases/2024/06/240619182323.htm
Amazon tells FCC to bin SpaceX's million-satellite datacenter dream
-
Calls Musk’s orbital plans “speculative” despite Bezos touting orbiting
compute
Amazon wants US regulators to reject a SpaceX application for permission t...
11 hours ago
No comments:
Post a Comment